Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 3 of 3 entries
Sorted by: Best Match Show Resources per page
MLK4 regulates DNA damage response and promotes triple-negative breast cancer chemoresistance.

Cell death & disease

Mehlich D, Łomiak M, Sobiborowicz A, Mazan A, Dymerska D, Szewczyk ŁM, Mehlich A, Borowiec A, Prełowska MK, Gorczyński A, Jabłoński P, Iżycka-Świeszewska E, Nowis D, Marusiak AA.
PMID: 34839359
Cell Death Dis. 2021 Nov 27;12(12):1111. doi: 10.1038/s41419-021-04405-0.

Chemoresistance constitutes a major challenge in the treatment of triple-negative breast cancer (TNBC). Mixed-Lineage Kinase 4 (MLK4) is frequently amplified or overexpressed in TNBC where it facilitates the aggressive growth and migratory potential of breast cancer cells. However, the...

Cite
Mehlich D, Łomiak M, Sobiborowicz A, et al. MLK4 regulates DNA damage response and promotes triple-negative breast cancer chemoresistance. Cell Death Dis. 2021;12(12):1111doi: 10.1038/s41419-021-04405-0.
Mehlich, D., Łomiak, M., Sobiborowicz, A., Mazan, A., Dymerska, D., Szewczyk, �. �. M., Mehlich, A., Borowiec, A., Prełowska, M. K., Gorczyński, A., Jabłoński, P., Iżycka-Świeszewska, E., Nowis, D., & Marusiak, A. A. (2021). MLK4 regulates DNA damage response and promotes triple-negative breast cancer chemoresistance. Cell death & disease, 12(12), 1111. https://doi.org/10.1038/s41419-021-04405-0
Mehlich, Dawid, et al. "MLK4 regulates DNA damage response and promotes triple-negative breast cancer chemoresistance." Cell death & disease vol. 12,12 (2021): 1111. doi: https://doi.org/10.1038/s41419-021-04405-0
Mehlich D, Łomiak M, Sobiborowicz A, Mazan A, Dymerska D, Szewczyk ŁM, Mehlich A, Borowiec A, Prełowska MK, Gorczyński A, Jabłoński P, Iżycka-Świeszewska E, Nowis D, Marusiak AA. MLK4 regulates DNA damage response and promotes triple-negative breast cancer chemoresistance. Cell Death Dis. 2021 Nov 27;12(12):1111. doi: 10.1038/s41419-021-04405-0. PMID: 34839359; PMCID: PMC8627512.
Copy Download .nbib Format: NLM
Potent but transient immunosuppression of T-cells is a general feature of CD71.

Communications biology

Grzywa TM, Sosnowska A, Rydzynska Z, Lazniewski M, Plewczynski D, Klicka K, Malecka-Gieldowska M, Rodziewicz-Lurzynska A, Ciepiela O, Justyniarska M, Pomper P, Grzybowski MM, Blaszczyk R, Wegrzynowicz M, Tomaszewska A, Basak G, Golab J, Nowis D.
PMID: 34893694
Commun Biol. 2021 Dec 10;4(1):1384. doi: 10.1038/s42003-021-02914-4.

CD71

Cite
Grzywa TM, Sosnowska A, Rydzynska Z, et al. Potent but transient immunosuppression of T-cells is a general feature of CD71. Commun Biol. 2021;4(1):1384doi: 10.1038/s42003-021-02914-4.
Grzywa, T. M., Sosnowska, A., Rydzynska, Z., Lazniewski, M., Plewczynski, D., Klicka, K., Malecka-Gieldowska, M., Rodziewicz-Lurzynska, A., Ciepiela, O., Justyniarska, M., Pomper, P., Grzybowski, M. M., Blaszczyk, R., Wegrzynowicz, M., Tomaszewska, A., Basak, G., Golab, J., & Nowis, D. (2021). Potent but transient immunosuppression of T-cells is a general feature of CD71. Communications biology, 4(1), 1384. https://doi.org/10.1038/s42003-021-02914-4
Grzywa, Tomasz M, et al. "Potent but transient immunosuppression of T-cells is a general feature of CD71." Communications biology vol. 4,1 (2021): 1384. doi: https://doi.org/10.1038/s42003-021-02914-4
Grzywa TM, Sosnowska A, Rydzynska Z, Lazniewski M, Plewczynski D, Klicka K, Malecka-Gieldowska M, Rodziewicz-Lurzynska A, Ciepiela O, Justyniarska M, Pomper P, Grzybowski MM, Blaszczyk R, Wegrzynowicz M, Tomaszewska A, Basak G, Golab J, Nowis D. Potent but transient immunosuppression of T-cells is a general feature of CD71. Commun Biol. 2021 Dec 10;4(1):1384. doi: 10.1038/s42003-021-02914-4. PMID: 34893694.
Copy Download .nbib Format: NLM
Potent but transient immunosuppression of T-cells is a general feature of CD71.

Communications biology

Grzywa TM, Sosnowska A, Rydzynska Z, Lazniewski M, Plewczynski D, Klicka K, Malecka-Gieldowska M, Rodziewicz-Lurzynska A, Ciepiela O, Justyniarska M, Pomper P, Grzybowski MM, Blaszczyk R, Wegrzynowicz M, Tomaszewska A, Basak G, Golab J, Nowis D.
PMID: 34893694
Commun Biol. 2021 Dec 10;4(1):1384. doi: 10.1038/s42003-021-02914-4.

CD71

Cite
Grzywa TM, Sosnowska A, Rydzynska Z, et al. Potent but transient immunosuppression of T-cells is a general feature of CD71. Commun Biol. 2021;4(1):1384doi: 10.1038/s42003-021-02914-4.
Grzywa, T. M., Sosnowska, A., Rydzynska, Z., Lazniewski, M., Plewczynski, D., Klicka, K., Malecka-Gieldowska, M., Rodziewicz-Lurzynska, A., Ciepiela, O., Justyniarska, M., Pomper, P., Grzybowski, M. M., Blaszczyk, R., Wegrzynowicz, M., Tomaszewska, A., Basak, G., Golab, J., & Nowis, D. (2021). Potent but transient immunosuppression of T-cells is a general feature of CD71. Communications biology, 4(1), 1384. https://doi.org/10.1038/s42003-021-02914-4
Grzywa, Tomasz M, et al. "Potent but transient immunosuppression of T-cells is a general feature of CD71." Communications biology vol. 4,1 (2021): 1384. doi: https://doi.org/10.1038/s42003-021-02914-4
Grzywa TM, Sosnowska A, Rydzynska Z, Lazniewski M, Plewczynski D, Klicka K, Malecka-Gieldowska M, Rodziewicz-Lurzynska A, Ciepiela O, Justyniarska M, Pomper P, Grzybowski MM, Blaszczyk R, Wegrzynowicz M, Tomaszewska A, Basak G, Golab J, Nowis D. Potent but transient immunosuppression of T-cells is a general feature of CD71. Commun Biol. 2021 Dec 10;4(1):1384. doi: 10.1038/s42003-021-02914-4. PMID: 34893694.
Copy Download .nbib Format: NLM
Showing 1 to 3 of 3 entries